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ORIGINAL ARTICLE
Categorisation of goals set using Goal Attainment Scaling for treatment of leg
spasticity: a multicentre analysis
Stephen Ashforda,b , Heather Williamsa, Ajoy Nairc, Samantha Orridged and Lynne Turner-Stokesa,b
aRegional Hyper-acute Rehabilitation Unit, Northwick Park Hospital, London, UK; bDepartment of Palliative Care, Policy and Rehabilitation,
Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King’s College London, London, UK; cAlderbourne Rehabilitation Unit,
Hillingdon Hospital, London, UK; dKings College Hospital, London, UK
ABSTRACT
Background: Goal-classification of person-centred goals, using Goal Attainment Scaling for leg spasti-
city treatment.
Methods: The study was conducted in two phases: phase I, a retrospective review to evaluate categories
of goal set in routine clinical practice. Findings were used to design a goal classification system. Phase II,
a multi-centre study to confirm the goal categories. Goals set (n¼ 270) were analysed from data collected
at three centres in the UK (one centre for phase I). Goal categories were mapped onto the domains of
the World Health Organisation, International Classification of Functioning Disability and Health.
Results: One hundred and twenty seven participants were recruited in two cohorts: phase I: 63; phase II:
64. Goal categories using both cohorts were assigned to two domains, each subdivided into three key
goal categories: Domain 1: body structure impairment 121 (44%): (a) pain/discomfort 34 (12%), (b) involun-
tary movements 20 (7%), and (c) range of movement/contracture prevention 67 (25%). Domain 2: activity
function 149 (56%): (a) passive function (ease of caring for the affected limb) n¼ 89 (33%), (b) active func-
tion (transfers) 26 (10%), and (c) active function (mobility) 27 (10%), other n¼ 7 (3%).
Conclusions: Patients individual leg spasticity goals can be grouped into six categories and two domains,
which will assist clinicians, patients and cares in setting and evaluating goals in practice.
 IMPLICATIONS FOR REHABILITATION
 Six goal areas used in clinical goal setting for leg spasticity management were identified, under the
two domains: (1) body structure impairment: pain, involuntary movements, and range of movement
and (2) activities/function: passive function (ease of caring), active function – transfers or standing
and active function – mobility.
 Categorisation of goals is consistent on repeated evaluation and across different clinical services.
 Using clinical goals for leg spasticity treatment is an effective method to identify treatment priorities.
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Introduction
Spasticity is a common and distressing consequence of acquired
brain injury, which interferes with leg movement and limits func-
tional tasks such as mobility and transfers, as well as increasing
the burden on caregivers assisting people with personal care [1].
Goals for treatment of leg spasticity often focus on improvements
in walking, standing, and transferring from different seated posi-
tions. However, depending on patient priorities for treatment and
individual aspirations, variation is seen in the focus of goals for
intervention.
Setting goals with patients and carers has become an integral
activity in clinical rehabilitation [2,3]. Goal Attainment Scaling is a
method of goal setting and scoring the extent to which a
patient’s individual goals are achieved in the course of interven-
tion, so that diverse outcomes may be captured on a single tool.
Originally described by Kiresuk and Sherman [4], Goal Attainment
Scaling has been used in many areas of practice that warrant an
individualised approach to outcome evaluation following complex
interventions, including rehabilitation [5,6].
Patients are more likely to engage positively in rehabilitation
directed towards goals that are important to them [3], and it has
been suggested that the Goal Attainment Scaling process may
provide an additional therapeutic benefit by encouraging patients
to strive towards their goals [7]. Goal Attainment Scaling also pro-
vides a structure for the discussion and agreement of goals and
expected levels of achievement with patients, their family and the
clinical team [5].
Despite adaptations, such as Goal Attainment Scaling-light
model [8] to make Goal Attainment Scaling simple to apply in
clinical settings, its uptake for routine clinical practice continues
to be constrained by the perceived time-consuming nature of
individualised goal setting. Concerns have also been raised about
lack of standardisation, which limits the comparability of Goal
Attainment Scaling across different populations and settings
[9,10]. Goal Attainment Scaling is not, in fact, a measure of out-
come per se, but a measure of the achievement of treatment
intentions and goal attainment. Therefore, it should not be used
in isolation, but in conjunction with standardised measures to
quantify the domains of goal achievement [11].
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Opponents of Goal Attainment Scaling argue that the aggrega-
tion of qualitatively different goals into a single overall score is
tantamount to combining apples with pears. However, a counter
argument to this criticism of Goal Attainment Scaling is that while
it may combine “apples” with “pears”, these are both types of fruit
(i.e., goals) and therefore may be linked by the higher order con-
struct of “goal attainment”.
The Goal Attainment Scaling approach has therefore been
used as an individualised outcome evaluation tool in clinical
studies of spasticity intervention [11–15]. The treatment of
upper limb spasticity with botulinum neurotoxin is an example
of a complex intervention where Goal Attainment Scaling has
been used to demonstrate the benefits of treatment in this
context [11–14,16]. In fact, Goal Attainment Scaling is now rec-
ommended in national and international guidelines as a method
of recording person-centred outcomes in this context [17,18].
However, the goals for treatment are by nature widely diverse,
crossing many domains of the World Health Organisation
International Classification for Functioning Disability and Health
[19]. This has led to a plethora of outcome measures used to
capture them, which in turn confounds the assimilation of evi-
dence to establish the effectiveness of treatment and compar-
ability between studies.
While there is value in the individual nature of Goal
Attainment Scaling goals, the ability to identify consistent goal
categories is potentially valuable in understanding outcome for
whole groups of patients, planning treatment interventions and in
identifying which interventions might work best for improved out-
comes in certain groups of patients. Following initial concerns
about lack of standardisation [20], work in arm spasticity manage-
ment has demonstrated that person-centred goals can be categor-
ised consistently into six main goal areas [21,22]. This has led to
the development of a structured approach combining individual-
ised goal setting with standardised measures targeted on the
patients priority goals for treatment [21] to make outcome meas-
urement more comparable.
Work to categorise goals in leg spasticity has not yet been
undertaken and this study aimed to identify, categorise and map
goals for spasticity intervention in the leg according to the World
Health Organisation International Classification of Functioning
Disability and Health [23], mirroring work previously undertaken
for arm spasticity.
Methods
This study had two phases.
Phase I was a retrospective review of goals set for focal leg
spasticity intervention following botulinum toxin injection and
physical management between January 2009 and January 2013.
The setting was a regional specialised rehabilitation service
(United Kingdom – Rehabilitation Outcomes Collaborative; desig-
nated hyper-acute and level 1) [24], with associated outreach and
spasticity service. All patients receiving botulinum toxin injection
for leg spasticity were included in the analysis and selection for
treatment was undertaken based on clinical need.
Phase II was a prospective consecutive cohort evaluation of
goal setting at three sites, including both botulinum toxin injec-
tion and physical management methods between November 2014
and June 2016. Inclusion in the cohort study was based on a clin-
ically identified need for spasticity management (including botu-
linum toxin injection) as part of a rehabilitation programme. Sites
were chosen purposively to reflect the range/types of specialist
spasticity services available in the UK, but applicable more widely.
The settings were:
1. An academic regional rehabilitation service, with associated
outreach (to other rehabilitation units, community and refer-
ring hospitals) and spasticity service.
2. A local specialist rehabilitation service with associated spasti-
city clinic.
3. A regional spasticity service based at a tertiary hospital.
The services represent the current range of services offering
spasticity management in the context of rehabilitation in the UK.
Ethics
Ethical approval for the study was granted by the National
Research Ethics Service Committee London – South East (14/LO/
1340). Informed consent procedures or consultation with next of
kin, prior to participation in phase II of this study was undertaken
with all participants in accordance with the ethical approval.
Recruitment
Phase I was a retrospective review of routinely collected data in a
cohort receiving spasticity management intervention. Data were
prospectively collected at the time of intervention and entered
into an electronic database designed for capture of routine data.
Phase II participants were recruited in a prospective cohort
study including goal setting prior to focal spasticity intervention
(botulinum toxin administration and physical management)
according to clinically identified need.
Goal setting procedure
A consistent goal setting procedure was used across phases I and
II. Goals were set according to the “Goal Attainment Scaling-Light”
methodology as described by Turner-Stokes [8], based on the ori-
ginal method of Kiresuk and Sherman [4]. In summary, goals are
identified to suit the individual and agreed by both the patient
(or their carer, if they are unable to participate) and the treating
team prior to starting treatment. Tightly defined goal definitions
are drawn up to be specific, measurable, achievable, realistic and
timed. The expected (predicted) level of outcome is recorded. A
five-point scale ranging from 2 to þ2 is used to evaluate out-
come using a verbal rating scale which is then assigned the
numeric ratings for calculation. A score of “0” reflects achievement
of the goal as expected, positive scores indicating achievement at
higher levels, and negative scores at lower levels than expected.
Typically, there is more than one goal for treatment and their
scores combined using a standard formula to derive a T-score
reflecting overall achievement of the predicted outcome following
assignment of the scores from the verbal rating in Goal
Attainment Scaling-Light.
Data collection
A standardised recording proforma (within an electronic database)
was used in the phase I retrospective cohort. In phase II, a further
development of the original proforma was used to simplify data
collection. In the phase II, prospective cohort, goal achievement
and any parameters or standardised measures used to provide
quantification for goal evaluation (e.g., 10 metre timed walk)
were collected.
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Data analysis
Goal statements were extracted, classified to determine goal cate-
gories in phase I. Classification of goals was completed by two
authors (LTS and SA) independently and then compared, with any
differences discussed and consensus reached. For classification,
“like goals” were initially grouped to identify the categories which
were based of frequency of goal type occurrence in the dataset.
The goal categories developed in phase I were then applied to
phase II confirming the classification structure. Goal categories
were then mapped onto the World Health Organisation
International Classification of Functioning Disability and Health
[23], to enable comparison to other current and future work inter-
nationally in this area. Mapping onto the ICF used the illustration
library from the International University of Health and Welfare,
Japan [25]. The illustration library allows the clear identification of
domains and sub-classifications, once the core goal parameter has
been identified. Mapping was undertaken independently by the
first author and reviewed by the other authors for agreement.
Results
In phase I, 195 patients assessed for spasticity management; of
which, 63 received botulinum toxin injection for leg muscle spasti-
city and combined physical interventions and were included as
participants in the retrospective cohort. The mean age was 56
(standard deviation 16.7), 29 (47%) male. The diagnoses were
stroke (n¼ 27), traumatic brain injury (n¼ 11), hypoxic brain injury
(n¼ 5), multiple sclerosis (n¼ 16), complex regional pain syn-
drome (n¼ 1), spinal cord injury (n¼ 1), or missing (n¼ 2).
In phase II, 65 participants consented, one patient refused clin-
ical intervention or assessment and was excluded, 64 participants
were therefore included in the prospective cohort. Mean age was
51 (standard deviation 17.4), 32 (50%) male. The diagnoses were
stroke (n¼ 34), traumatic brain injury (n¼ 10), hypoxic brain injury
(n¼ 5), multiple sclerosis (n¼ 8), brain tumour (n¼ 6), or spinal
cord injury (n¼ 1).
In phase II, median (interquartile range) EQ-5D (health related
quality of life scale; range 0–100) was 60 (43.7–80), indicating a
substantial impact on quality of life. The Rivermead Mobility Index
was 1 (0–7.7) indicating marked functional impairment and
reduced mobility. Modified Ashworth Scale composite score (a
summed score was produced for hip, knee and ankle) was 13
(8–18) indicating severe spasticity in this group. These data were
not available in phase I.
In phases I and II, we acknowledge the small numbers in the
diagnostic group of spinal cord injury, however the focus in this
work is goal setting for management of a symptom (spasticity)
within a rehabilitation programme. Therefore, relevance to spasti-
city within rehabilitation is the priority, rather than the diagnostic
category, and these subjects were therefore retained for analysis.
In total, 270 individualised goals for treatment of leg spasticity
following botulinum toxin injection and physical rehabilitation
were analysed. In phase I, 62 participants had two goals (one par-
ticipant had a single goal) and in phase II the number of goals
ranged between 2 and 4, with 49 (75%) having two goals. Goal
classification is summarised in Table 1.
A list of percentage goal achievement, parameters, or standar-
dised measures used to quantify goal outcome identified in each
goal area during phase II are presented in Table 2. This informa-
tion was not routinely collected in phase I.
Following goal categorisation by the two independent authors,
mapping onto the World Health Organisation International
Classification of Functioning Disability and Health was performed
(see Table 3).
Discussion
In this evaluation, goal categories could be assigned to two
domains, each subdivided into three key goal areas: domain 1
body structure impairment: pain/discomfort, involuntary move-
ments, range of movement/contracture prevention. Domain 2
activity function: passive function (ease of caring for the affected
limb), active function (transfers), and active function (mobility). In
addition, a small number of goals were also identified for therapy
facilitation and cosmetic appearance of the leg.
The findings have been used to inform the development of a
structured approach to goal setting; Goal Attainment Scaling –
Leg, which is a structured process for applying Goal Attainment
Scaling alongside recording of standardised measures and avail-
able from: https://www.kcl.ac.uk/nursing/departments/cicelysaun-
ders/attachments/GASlegs-V2–4.pdf. The Goal Attainment Scaling
– leg should help patients, carers and clinicians establish agreed
goals and facilitate outcome assessment in a manner supportive
of the rehabilitation programme.
This evaluation demonstrated that the leg impairment and pas-
sive function categories are broadly similar to those identified in
earlier work classifying goals in arm spasticity [21]. The exception
was active function, which is divided into transfers and walking
for the leg. Though the categories of goals set in the arm and the
leg are similar for spasticity management, the proportions of goals
set in different categories were different. Prospective comparison
of this within the same cohort would be valuable to determining
likely goal setting priorities and achievement rates to patients in
clinical practice to aid care planning in the future.
In this analysis of goals set for management of leg spasticity
with in a rehabilitation context, a number of standardised meas-
ures were applied alongside goal setting for evaluation of out-
come (see Table 2). There was a degree of consistency in this
study, with which measures were applied for the different catego-
ries of goal.
Table 1. Combined proportion of goals set in the identified categories from phases I and II.
Combined analysis from:
Phase I n¼ 63 patients (125 goals)
Phase II n¼ 64 patients (145 goals)
Goal domain (270 goals) Goal categories No. of goals set % of goals set
Body structure Impairment 121 goals (45%) Pain 34 12%
Involuntary movements 20 7%
Contracture prevention and range of movement 67 25%
Activities 149 goals (55%) Passive function 89 33%
Active function Transfers 26 10%
Active function Mobility 27 10%
Other; therapy facilitation and cosmesis – body perception 7 3%
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In domain 1 (body structure impairment): pain or discomfort
was measured by a 10-point Numerical Rating Scale; involuntary
movements were evaluated using spasm frequency count; range
of movement was evaluated by goniometry or an another ana-
tomical measurement (e.g., inter-knee distance) and contracture
prevention by splint application length of time. In domain 2
(activity): passive function (ease of caring for the affected limb),
the measures used were more varied, but included, ease of care
rating on a 10-point numeric scale, the Leg Activity measure [26]
and time to complete a care task. The active function-transfers
category was evaluated by ability or time taken to complete the
“transfer” or Leg Activity measure. The active function-mobility
category was evaluated by timed walk (10 meter or 6 meter),
walking endurance (6min walk), falls frequency, video recording,
rating of confidence when walking (10-point numeric scale) and
Leg Activity measure.
Measures were associated with the categories of goals set and
often referred to in the goal statement as a measure of goal
achievement. There was a degree of consistency in the use of
measures per goal category, but it would be helpful to explore
this further in a larger sample including practice at more centres.
The current evaluation has a number of limitations. First, the
study was conducted in the UK health system and, has not been
tested in other health systems. However, earlier work for arm
spasticity identified a similar classification with data collected from
a number of different countries [21], so conducting a similar study
for leg spasticity should be possible in the future. Second, the
data collection in phase I of this work was not done with the
Table 2. Breakdown of goals set (145) and standard measures used in each goal area in phase II.
Goal domain Goal area No. of goals set (% of total)
No. of goals achieved (%
of category)
Goal parameters/standard meas-
ures useda
Body structure impairment 76
goals (52%)
Spasticity-related pain or discomfort 24 (17%) 16 (67%) Numerical Rating Scale (n¼ 22)
Involuntary movements during activ-
ities or care (associated reactions)
or spasms
17 (11%) 10 (58%) Spasm frequency (n¼ 5)
Range of movement, prevention of
contractures/deformity,
splint tolerance
35 (25%) 24 (69%) Goniometry, anatomical distan-
ces (e.g., inter-knee distance)
(n¼ 8), splint tolerance
times (n¼ 20)
Activities 69 goals (48%) Passive function – ease of caring for
the affected limb (e.g., maintaining
hygiene, skin integrity, dressing
the limb)
38 (26%) 29 (76%) Ease of care or carer burden rat-
ings (10-point numerical rat-
ing) (n¼ 33), time to
complete task, (n¼ 4)
Leg Activity measure – passive
function (n¼ 34)
Active function – transfers or standing
using the limb in an active func-
tion task
11 (7%) 9 (81%) Ability to complete the defined
task (n¼ 4), time taken
(n¼ 3), control/quality of
movement (n¼ 2)
Leg Activity measure – active
function (n¼ 9)
Active function – improved mobility
(e.g., walking, avoiding falls)
15 (10%) 9 (59%) Gait speed (10 metre walk,
6minute walk), endurance
(6minute walk), video, falls
frequency, confidence rating
(10-point numerical rating)
(n¼ 7)
Leg Activity measure – active
function (n¼ 13)
Other, therapy facilitation and cosme-
sis – perception of body image
5 (4%) 3 (60%) Three of these were for the
facilitation of therapy and
none included a standardised
measure or goal parameter
Total 145 (100%) 100 (69%)b
aAll standardised measures or ordinal scales used to quantify goal attainment are indicated.
bPercentage of 145 total.
Table 3. Mapping of goal categories onto the relevant World Health Organisation International Classification of Function Disability and Health codes.
Domain Goal area Chapter Primary ICF code Associated ICF codes
Body structure and function
Pain 2 – Sensory & pain b280 – Pain b735
Passive range of movement 7 – Neuro-musculoskeletal b735 – Muscle tone b710
Reducing associated reactions 7 – Neuro-musculoskeletal b755 – Involuntary movement reactions to position/balance b735
Activity and participation
Maintaining postures 4 – Mobility d415 – Maintaining body position d445
Improved walking/gait pattern 4 – Mobility d450 – Walking d420
Transferring 4 – Mobility d420 – Transferring d410, d415
Changing position 4 – Mobility d410 – Changing body position d415, d420
General Independence 5 – Self care d500 – General Independence b510-washing
Hygiene/skin integrity 5 – Self care d520 – Caring for body parts b735, b710, b510
Caring for the leg 5 – Self care d520 – Caring for body parts b735, b710, b510
Dressing 5 – Self care d540 – Dressing d440, b735, d710
ICF: International Classification of Functioning Disability and Health.
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same rigour as data collection in phase II. While the same catego-
ries were found in the domains of impairment and activity func-
tion there were some differences in the number of goals set and
the proportions set under each category. Rigorous monitoring of
the goal setting process seemed to address this issue in phase II.
Some goals in both phases I and II contained potential multiple
categories for which the primary category was used to classify the
goal. In practice, this did not lead to disagreement and classifica-
tion was generally clear, but could be considered a limitation.
Third, while it was possible to classify most goals according to the
World Health Organisation International Classification of Function
Disability and Health, this was not so in every case. Those goals
categorised as “other” were not possible to classify because they
did not relate directly to body structure and function, activity or
participation. This category contained a relatively small number of
goals. Those related to therapy facilitation were likely to be work-
ing towards elements that could be classified as activity or partici-
pation, but not the goal statements as written.
This analysis supports the premise that, despite their diversity,
goals for management of leg spasticity, as previously demon-
strated in arm spasticity, can be broadly categorised. The
approach of identifying the common goal areas and associated
standardised measures used in conjunction with them, is not con-
fined to the management of spasticity, but has the potential for
wider application in rehabilitation. Use of standardised measures
alongside goals was valuable in quantifying and measuring the
outcome of the goals set and can be considered as an approach
to evaluate goal related outcome in rehabilitation more widely.
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